Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy
My. Chen et al., Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy, CLIN INF D, 32(9), 2001, pp. 1361-1365
We discovered a patient with AIDS with persistent B19 infection who had slo
w resolution of anemia after he commenced receiving HAART without intraveno
us immunoglobulin. The patient's anemia recurred when the initial course of
HAART failed, but it remitted slowly after salvage therapy was instituted.
However, circulating B19 was still detectable by nested polymerase chain r
eaction 1 year after commencement of salvage therapy. Immunoglobulin G and
immunoglobulin M antibodies against B19 were not detected by means of enzym
e-linked immunosorbent assay when the anemia initially resolved, but they w
ere detected after the patient commenced receiving salvage therapy. The abs
ence of antibody response after the initial remission of parvovirus B19 inf
ection suggested that cellular immunity was an important component of recon
stituted immune function against B19 after the patient received HAART. The
humoral response that was restored later was abnormal; it had strong reacti
vity to nonstructural protein NS-1 and poor generation of neutralizing anti
bodies against linear epitopes unique to minor capsid protein VP1.